A "Famous Medication" with Magical Effects: Goodbye to Obesity

On Friday, the U.S. Food and Drug Administration approved the use of a well-known diabetes medication to treat obesity, a step that could help many avoid obesity-related diseases. The British newspaper "Daily Mail" reported on Saturday that the drug Wegovy will be provided to those looking to lose weight, especially since it is a synthetic version of an intestinal hormone that reduces appetite. The drug is administered weekly through subcutaneous injection and is currently used to treat type 2 diabetes. Experts stated that the effectiveness of the drug also depends on following a healthy diet and continuing to exercise, as more than 100 million American adults are suffering from obesity. Obesity is recognized as a risk factor for chronic health conditions, including type 2 diabetes, strokes, heart attacks, and even certain types of cancer. A study conducted to determine the effectiveness of the treatment found that participants who received the treatment lost about 15% of their body weight, equivalent to 34 pounds, over 16 months, while a group receiving a placebo lost about 2.5% of their body weight. Harold Baez, the medical director of the "Louisville" Center for Metabolic Research and Arteriosclerosis, stated that current medications might help with weight loss ranging from 5% to 10%, and sometimes may not even achieve that. Baez has assisted in conducting further studies regarding Wegovy and other diabetes and obesity treatments.